Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Ciba Vision seeks approval of Rescula on two continents for treatment of glaucoma

March 14, 2000

Alocril now available in U.S. for itch associated with allergic conjunctivitis

March 2, 2000

Santen seeks FDA approval of levofloxacin for bacterial conjunctivitis

March 1, 2000

Allergan and Dura enter commercialization agreement for multiple products

Feb. 25, 2000

GenVec licenses gene for treating blindness

Feb. 24, 2000

Oxigene to develop CA4P for eye, skin and joint disorders

Feb. 23, 2000

New selectin inhibitor SKK-60060 shows promise in treatment of uveitis

Feb. 22, 2000

Blockade of VEGF alone is sufficient to prevent blinding illness

Feb. 21, 2000

Novel Merck compounds inhibit KDR kinase and VEGF activity

Feb. 15, 2000

Ophthalmic antibacterial on the way to market in Japan

Feb. 15, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...